Skip to main content
See every side of every news story
Published • loading... • Updated

Barclays Issues Pessimistic Forecast for CVS Health (NYSE:CVS) Stock Price

Summary by MarketBeat
Barclays dropped their target price on shares of CVS Health from $108.00 to $107.00 and set an "overweight" rating for the company in a report on Thursday.

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Thursday, November 5, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal